Floatz logo

RAMIFENTANYL

Bariatric Surgery Candidate

Hospital dos LusíadasSmall moleculePhase 4 / ApprovedActive
BBB
73/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
63/ 100
Competitive Position
89/ 100

Competitive context

65 Active assets in the Bariatric Surgery Candidate cohort.

Asset / SponsorPhaseRating
LIDOCAINE
Instituto Mexicano del Seguro Social
Phase 4BBB
Chenodeoxycholic Acid
Hvidovre University Hospital
Phase 4BBB
PROPOFOL
G.Gennimatas General Hospital
Phase 4BBB
Colesevelam
Hvidovre University Hospital
Phase 4BBB
Semaglutide
Zuyderland Medisch Centrum
Phase 4BBB

View all 50 →

Same molecule, other indications

RAMIFENTANYL is also rated in:

cardiovascular disorderDormant
BBB
Indicative ·
73 / 100
View asset →
Anesthesia, GeneralDormant
BBB
Indicative ·
73 / 100
View asset →
Anesthesia, LocalDormant
BBB
Indicative ·
73 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →